Approaches to Individualized Treatment for Chronic Lymphocytic Leukemia: Expert Guidance on Sequencing Therapy, Novel Agents, and Their Combinations

In this satellite symposium, experts discuss the optimal management strategy for patients with CLL, including evidence-based best practices and practical application of the NCCN Guidelines. Download the slides from this dynamic satellite symposium and a clinician resource to learn more about current treatment algorithm and ongoing clinical trials in CLL.
Jeremy S. Abramson, MD, MMSc
William G. Wierda, MD, PhD

Downloadable Slidesets

Download these slides from our live satellite symposium on CLL to review the most recent clinical data on new agents in both frontline and relapsed/refractory CLL.

Jeremy S. Abramson, MD, MMSc William G. Wierda, MD, PhD Released: September 26, 2019
Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC

Karen Kanefield
Manager CE Accreditation & Program Operations
National Comprehensive Cancer Network
3025 Chemical Road, Suite 100
Plymouth Meeting, PA 19462

215-690-0283 (Fax)
For Clinicians:
For Patients:

This activity is supported by an educational grant from AstraZeneca.

This activity is supported by an independent medical education grant from Pharmacyclics LLC and Janssen.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.